Debt-free Balance SheetA zero-debt balance sheet is a durable financial strength: it reduces refinancing and interest-rate exposure, preserves strategic optionality for R&D or scale-up financing, and gives management time to pursue commercialization without immediate solvency pressure despite operating losses.

Fermentation-based Production PlatformBioextrax’s core capability in fermentation and downstream processing targets PHA and bacterial cellulose, aligning with structural demand for sustainable bioplastics. Proprietary process tech and scale-up focus are lasting competitive assets if commercial economics improve and customer adoption grows.

Evidence Of Operating Leverage PotentialHistory shows an instance of positive gross profit, indicating the business model can reach profitable unit economics under better scale or lower input costs. This suggests durable upside if revenue scales and production efficiency improvements persist beyond a single year.

Bears Say

Structurally Negative ProfitabilitySustained negative gross margins and deep operating losses across multiple years signal a structural mismatch between current cost base and revenue. Without consistent margin improvement the company will continue eroding capital and cannot reliably self-fund growth.

Consistent Cash Burn, Accelerated In 2025Persistent negative operating and free cash flow, with acceleration in 2025, creates a durable funding need. Even with no debt, the company will likely require external capital to sustain operations or scale production, raising dilution or financing risk over the medium term.

Very Small, Declining Revenue BaseA small, volatile and recently declining revenue base prevents stable scale economics and makes fixed-cost absorption difficult. This structural revenue weakness increases execution risk and lengthens the timeline to reach sustainable margins or commercial profitability.

Bioextrax AB News

Is 85X0 a Buy, Before Earnings?

Bioextrax AB (85X0) is scheduled to report 4th quarter earnings on 02/19/2026. Regarding Q4 estimates, Wall Street analysts...

21d ago

BIOEX FAQ

What was Bioextrax AB’s price range in the past 12 months?

Bioextrax AB lowest stock price was kr1.60 and its highest was kr3.98 in the past 12 months.

What is Bioextrax AB’s market cap?

Bioextrax AB’s market cap is kr126.88M.

When is Bioextrax AB’s upcoming earnings report date?

Bioextrax AB’s upcoming earnings report date is May 14, 2026 which is in 65 days.

How were Bioextrax AB’s earnings last quarter?

Bioextrax AB released its earnings results on Feb 19, 2026. The company reported -kr0.11 earnings per share for the quarter, missing the consensus estimate of kr0 by -kr0.11.

Is Bioextrax AB overvalued?

According to Wall Street analysts Bioextrax AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Bioextrax AB pay dividends?

Bioextrax AB does not currently pay dividends.

What is Bioextrax AB’s EPS estimate?

Bioextrax AB’s EPS estimate is -0.1.

How many shares outstanding does Bioextrax AB have?

Bioextrax AB has 46,306,927 shares outstanding.

What happened to Bioextrax AB’s price movement after its last earnings report?

Bioextrax AB reported an EPS of -kr0.11 in its last earnings report, missing expectations of kr0. Following the earnings report the stock price went up 5.98%.

Which hedge fund is a major shareholder of Bioextrax AB?

Currently, no hedge funds are holding shares in SE:BIOEX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Bioextrax AB

Bioextrax AB (BIOEX) is a Swedish biotechnology company that focuses on developing and commercializing environmentally sustainable technologies for converting waste materials into valuable products. The company operates in the sectors of bio-based materials and waste management, offering innovative solutions for the production of bioplastics, animal feed, and other materials using its proprietary microbial processes.